![Citeline Podcasts artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/0f/4f/ef/0f4fef8f-28fc-8de1-8d89-184cfda23e39/mza_5528053617673757912.jpg/100x100bb.jpg)
Device Week, 25 March 2021 – Abernethy Leaves FDA, Dermal Fillers Meeting
Citeline Podcasts
English - March 25, 2021 21:21 - 9 minutes - 5.66 MB - ★★★★★ - 24 ratingsBusiness News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Scrip’s Five Must-Know Things – 22 March 2021
Next Episode: Scrip’s Five Must-Know Things – 29 March 2021
This week’s podcast tackles FDA second-in-command Amy Abernethy’s surprise announcement that she’s leaving the agency. Then, we reveal how an FDA panel thinks dermal fillers like Restylane can be made safer for consumers following a recent uptick in serious adverse events.